We are live on
!
Find out more
ZCA
Zeke Capital Advisors Portfolio holdings
AUM
$1.53B
1-Year Est. Return
17.37%
This Fund
S&P 500
This Quarter
Est. Return
+4.75%
1 Year Est. Return
-17.37%
3 Year Est. Return
+41%
5 Year Est. Return
+67.71%
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$13.3M
(-1.2%)
Cap. Flow
-$44.9M
Cap. Flow
% of AUM
-4.23%
Top 10 Holdings %
Top 10 Hldgs %
28.84%
Holding
588
New
29
Increased
171
Reduced
213
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
|
+$4.47M |
| 2 |
Corning
GLW
|
+$1.95M |
| 3 |
NOV
NOV
|
+$1.93M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.51M |
| 5 |
Wells Fargo
WFC
|
+$1.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GDEN
Golden Entertainment
GDEN
|
+$14.3M |
| 2 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$13.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.14M |
| 4 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$3.76M |
| 5 |
American International
AIG
|
+$2.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.41% |
| 2 | Financials | 13.71% |
| 3 | Technology | 11% |
| 4 | Communication Services | 9.36% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vertex Pharmaceuticals
VRTX
$121B
| $624K | 0.06% |
3,402
-24
| -0.7% | -$4.2K |
|
302
Prologis
PLD
$135B
| $621K | 0.06% |
7,747
| – | – |
|
303
Clean Harbors
CLH
$16.5B
| $620K | 0.06% |
8,722
-1,512
| -15% | -$105K |
|
|
JHG
304
DELISTED
Janus Henderson
JHG
| $620K | 0.06% |
28,965
| – | – |
|
305
Edwards Lifesciences
EW
$49.6B
| $619K | 0.06% |
10,059
-1,050
| -9% | -$63.5K |
|
|
BRKL
306
DELISTED
Brookline Bancorp
BRKL
| $609K | 0.06% |
39,615
| – | – |
|
307
Chipotle Mexican Grill
CMG
$47.2B
| $609K | 0.06% |
41,550
-2,500
| -6% | -$35.2K |
|
308
C.H. Robinson
CHRW
$17.4B
| $608K | 0.06% |
7,210
-1,615
| -18% | -$136K |
|
|
XLRN
309
DELISTED
Acceleron Pharma
XLRN
| $608K | 0.06% |
14,796
-2,897
| -16% | -$120K |
|
310
Delta Air Lines
DAL
$57.5B
| $607K | 0.06% |
10,702
+225
| +2% | +$12.6K |
|
311
LPL Financial
LPLA
$28.3B
| $602K | 0.06% |
7,379
-784
| -10% | -$62K |
|
|
K
312
DELISTED
Kellanova
K
| $596K | 0.06% |
11,852
+85
| +0.7% | +$4.51K |
|
|
XLNX
313
DELISTED
Xilinx Inc
XLNX
| $595K | 0.06% |
5,050
-41
| -0.8% | -$4.78K |
|
314
Hartford Financial Services
HIG
$38.9B
| $593K | 0.06% |
10,643
| – | – |
|
315
Roper Technologies
ROP
$38.8B
| $592K | 0.06% |
1,615
| – | – |
|
|
CLDT
316
Chatham Lodging
CLDT
$622M
| $590K | 0.06% |
31,254
| – | – |
|
317
NiSource
NI
$21.3B
| $590K | 0.06% |
20,490
| – | – |
|
|
EXAS
318
DELISTED
Exact Sciences
EXAS
| $585K | 0.06% |
+4,953
| New | +$499K |
|
319
HCA Healthcare
HCA
$87.2B
| $585K | 0.06% |
4,328
-581
| -12% | -$73.5K |
|
320
Flowserve
FLS
$9.71B
| $583K | 0.05% |
11,073
| – | – |
|
321
Alnylam Pharmaceuticals
ALNY
$27.5B
| $581K | 0.05% |
8,008
+733
| +10% | +$56.2K |
|
322
Parker-Hannifin
PH
$123B
| $580K | 0.05% |
3,409
+369
| +12% | +$63.6K |
|
323
Equifax
EFX
$20.3B
| $579K | 0.05% |
4,280
-41
| -0.9% | -$5.14K |
|
324
Twilio
TWLO
$30B
| $579K | 0.05% |
4,249
| – | – |
|
|
ENV
325
DELISTED
ENVESTNET, INC.
ENV
| $566K | 0.05% |
8,280
| – | – |
|
Similar funds
GJIC
SBL
TFS
S
LWAC
SGA
BOTW
PIM
Zeke Capital Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Zeke Capital Advisors held 588 positions worth $1.06B, down 1.2% from $1.08B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Zeke Capital Advisors withdrew a net $44.9M in Q2 2019, closing 25 positions and reducing 213 holdings. Its most notable exit was Schwab Fundamental US Large Company Index ETF, an estimated $13.3M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Zeke Capital Advisors opened a new position in iShares 3-7 Year Treasury Bond ETF worth $1.53M.
- Zeke Capital Advisors's largest Q2 2019 buy was iShares 3-7 Year Treasury Bond ETF: 12,208 shares worth $1.53M.
- Zeke Capital Advisors added most to Zynerba Pharmaceuticals, Inc in Q2 2019, an estimated $4.47M increase.
- Zeke Capital Advisors's biggest Q2 2019 reduction was Golden Entertainment, cutting an estimated $14.3M.
- Zeke Capital Advisors fully exited Schwab Fundamental US Large Company Index ETF in Q2 2019, selling an estimated $13.3M.
- Zeke Capital Advisors's ten largest holdings make up 29% of its $1.06B portfolio in Q2 2019.
- Zeke Capital Advisors opened 29 new positions and closed 25 in Q2 2019.
- Zeke Capital Advisors's portfolio value fell 1.2% quarter-over-quarter to $1.06B.
Based on Zeke Capital Advisors's 13F filing for Q2 2019, filed 24 Jul 2019.